Orion (ORINF)
PNK: ORINF
· Real-Time Price · USD
48.65
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 48.65 |
| Market Cap | 6.84B |
| Revenue (ttm) | 1.59B |
| Net Income (ttm) | 347.5M |
| EPS (ttm) | 2.47 |
| PE Ratio (ttm) | 19.7 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 48.65 |
| Volume | 43 |
| Avg. Volume (20D) | 1.965 |
| Open | 47.16 |
| Previous Close | 48.65 |
| Day's Range | 47.16 - 48.65 |
| 52-Week Range | 38.38 - 48.65 |
| Beta | 0.43 |
About ORINF
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompe...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date May 28, 2013
Employees 3,943
Stock Exchange PNK
Ticker Symbol ORINF
Website https://www.orion.fi
